Marché mondial du syndrome de Kabuki – Tendances et prévisions de l’industrie jusqu’en 2030

Analyse du marché et de la taille du syndrome de Kabuki

Le syndrome de Kabuki a été observé pour la première fois dans la littérature médicale en 1981 par des médecins japonais. Le trouble était initialement connu sous le nom de syndrome de Kabuki-syndrome de maquillage car les traits du visage de nombreux enfants affectés ressemblaient au maquillage utilisé par les acteurs du syndrome de Kabuki, une forme de théâtre japonais. Le retard de croissance est fréquent chez les personnes atteintes du syndrome de Kabuki et devient généralement visible au cours de la première année de vie.

Data Bridge Market Research analyse le taux de croissance du marché du syndrome de kabuki au cours de la période de prévision 2023-2030. Le TCAC attendu du marché du syndrome de kabuki a tendance à être d'environ 8 % au cours de la période de prévision mentionnée. Le marché était évalué à 1,78 milliard USD en 2022 et devrait atteindre 3,3 milliards USD d'ici 2030. En plus des informations sur le marché telles que la valeur marchande, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe de Data Bridge Market Research comprend également une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.

Portée et segmentation du marché du syndrome de Kabuki

Market Definition

Kabuki syndrome is a kind of a rare multisystem disorder that is characterized by multiple abnormalities distinctive facial features, counting growth delays, variable degrees of intellectual disability, skeletal abnormalities and short stature. An extensive variety of additional symptoms affecting multiple organ systems can potentially occur. The particular symptoms associated with Kabuki syndrome syndrome can vary greatly from one person to another.

Kabuki Syndrome Market Dynamics

Drivers

• Increase in Diagnostic Tests

Different diagnostic tests used for treating kabuki syndrome are increasing the market growth. Sequence analysis followed by deletion/duplication analysis of KMT2D is characteristically performed first, as many of the individuals with this syndrome will have a mutation in this gene. Genetic testing for a mutation in KDM6A may be considered first for families in which X-linked inheritance is suspected.

Opportunities

• Increase in the number of research and development activities    

The market growth is pushed by an increase in the number of R&D activities. This will provide advantageous opportunities for the kabuki syndrome market growth. To encourage researchers and pharmaceutical companies to develop advanced medicines, the government is funding R&D initiatives.

• Emergence of New Varied Treatments

The new growing research organizations in the market are equipped with and utilize the knowledge of professionals in many clinical disciplines, leading to important advances in understanding this syndrome. Special services that may be advantageous to affected children include special remedial education, physical and occupational therapy, and speech therapy. Sensory integration therapy, wherein certain sensory activities are undertaken to help regulate a child’s response to sensory stimuli, may be used in some cases.

Restraints/Challenges

• Lack of skilled professionals

The lack of qualified healthcare professionals unable to perform these treatments could limit the growth of the kabuki syndrome market during the forecast period.

• High Cost

The huge expenditure that is required for its treatment processes impede the market growth. Numerous market players make huge investments in manufacturing new and advanced treatment procedures to faster the recovery process and in return the cost is increased.

This kabuki syndrome market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the kabuki syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Kabuki Syndrome Market Scope

The kabuki syndrome market is segmented on the basis of symptoms, gender, treatment, end-user distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Symptoms

• Distinctive Facial Features
• Mental Impairment
• Growth Problems
• Speech Delays
• Dental Abnormalities
• Skeletal Abnormalities
• Heart Abnormalities

Gender

• Male
• Female

Treatment

• Medication
• Surgery

End-Users

• Hospitals
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacies
• Others

Kabuki Syndrome Market Regional Analysis/Insights

The kabuki syndrome market is analyzed and market size insights and trends are provided by symptoms, gender, treatment, end-user distribution channel as referenced above.

The major countries covered in the kabuki syndrome market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is dominating the market in the forecast period due to rise in government funding and well-developed healthcare infrastructure.

Asia-Pacific is considered to grow over the coming years due to the increase in public awareness regarding the genetic disorders.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Analyse du paysage concurrentiel et des parts de marché du syndrome de Kabuki dans le monde

Le paysage concurrentiel du marché du syndrome de kabuki fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché du syndrome de kabuki

Les principaux acteurs opérant sur le marché du syndrome de kabuki comprennent :

• Novartis SA (Suisse)
• F. Hoffmann-La Roche SA (Suisse)
• Pfizer Inc. (États-Unis)
• Bayer AG (Allemagne)
• Société Bristol Myers Squibb (États-Unis)
• Novo Nordisk A/S (Danemark)
• GSK Plc. (Royaume-Uni)
• AstraZeneca (Royaume-Uni)
• Cadila Pharmaceuticals (Inde)
• Sun Pharmaceutical Industries Ltd. (Inde)
• DAIICHI SANKYO COMPANY, LIMITED (Japon)
• Amgen Inc. (États-Unis)

SKU-61638